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Abstract
We present 24-hour electrocardiography recording with observed DDD pacemaker pacing inhibition. Discussed Holter 
monitoring fi ndings are puzzling and may result from pacemaker sensing malfunction. However, its aetiology may be 
diverse. The detailed explanation of underlying mechanisms is provided and literature is reviewed.
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Introduction
Analysis of electrocardiography (ECG) recording in patients 
with cardiovascular implantable electronic devices (CIED) 
may be challenging. We would like to approach this issue 
in a problem-based learning manner.
An 80-year-old woman with a history of arterial hyper-
tension, dyslipidaemia, hypothyreosis, and a dual-chamber 
pacemaker (DDD, St. Jude Medical Verity ADx XLDR) pre-
sented to clinic for routine follow-up. She reported worse 
disposition, weakness and dizziness for 2 months. Her 
pacemaker was interrogated. The pacemaker was program-
med to DDD pacing mode. Table 1 shows the basic pacing 
programming of the device.
DDD pacemaker was implanted due to signifi cant bra-
dycardia and sick sinus syndrome. Active fi xation, bipolar, 
ventricular lead (Medtronic, CapSureFixNovus) was implan-
ted into right ventricular outfl ow tract (RVOT) through left 
subclavian vein puncture, while another passive fi xation, 
bipolar (Biotronik, Synox SX 53 JBP) atrial lead was located 
within right atrial appendage using left cephalic vein ve-
nesection. The Holter ECG monitoring was performed and 
its selected parts are shown on Figure 1. What caused the 
Table 1. Programmed device parameters
Mode DDD
Base rate [beats/min] 60
Paced atrioventricular delay [ms] 170
Sensed atrioventricular delay [ms] 150
Ventricular refractory period [ms] 280
Hysteresis Off
Night program Off
Pacing Unipolar
Sensing Bipolar
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pacemaker inhibition? Does the patient need any further 
clinical evaluation or management?
Discussion
In pacemaker-dependent patients, pacemaker inhibi-
tion may result in syncope, imbalance and/or dizziness 
recurrence. This fi nding may be recorded during Holter ECG 
monitoring [1]. Very similar ECG recordings can be seen 
with different mechanisms. Most physicians know that it 
may be the result of myopotentials noise in the presence 
of unipolar leads or when unipolar sensing is turned on [2]. 
Presented patient history suggests pacemaker malfunction, 
but no unipolar lead was implanted. In the presence of 
bipolar leads, inhibition of pacemaker programmed into 
bipolar sensing should not occur [3]. However, pacing 
inhibition during bipolar sensing may take place when the 
lead is damaged [4] or when some algorithms promoting 
endogenous ventricular depolarization are turned on [5, 6].
Exact interpretation of recorded fi ndings in our patient 
is possible in the context of basic DDD pacemaker time 
intervals understanding, which include:
 — lower rate interval (LRI) — the longest interval, during 
which no sensed events are observed; it is measured 
from paced or sensed ventricular event to the following 
paced ventricular stimulus;
 — paced atrioventricular interval (PAVI) — timeframe be-
tween atrial pacing and programmed ventricular pacing;
 — atrial escape interval (AEI), also called V-A interval — 
timeframe measured from sensed or paced ventricular 
event to atrial stimulus, provided that no atrial or ven-
tricular event is sensed (AEI = LRI – PAVI);
 — ventricular refractory period (VRP) — interval that begins 
with ventricular event during which ventricular lead 
sensing is blocked, therefore no LRI may begin.
Movements of the pacemaker pocket region during 
pacemaker control may help to put the right diagnosis. 
Figure 2 shows resting ECG and EGM which reveal DDD 
pacemaker inhibition during this practical manoeuvre. Due 
to damaged ventricular lead, pacemaker lead movements 
caused noise oversensing, which was interpreted by the 
pacemaker as ventricular activity (VS, visible in marker 
channel) and led to pacemaker inhibition (both atrial and 
ventricular pacing was inhibited). Atrial lead was in working 
order and did not read noise from ventricular lead (marker 
channel), from the heart or damaged atrial lead (which 
would lead to only atrial pacing inhibition).
Pacemaker inhibition may be caused by old and effi -
cient unipolar leads (or new ones programmed to unipolar 
sensing) which may read myopotentials from the thoracic 
or even abdominal muscles [7]. Against pacemaker inhi-
bition by myopotentials or electromagnetic fi eld, in this 
case, is the fact, that artefacts were present only in the 
ventricular channel. This would not be possible, when both 
unipolar leads would be implanted. On the other hand, in 
the case of algorithms promoting endogenous ventricular 
depolarization (i.e. Medtronic’s Minimal Ventricular Pacing 
algorithm) no noise would be observed.
In our case, pacing system included new (ca. 10-year-
-old) bipolar leads which advantage should be resistance 
towards reading noise from skeletal muscles myopoten-
tials and from external electromagnetic fields. The cause 
of pacemaker inhibition was ventricular lead damage. 
Which could be also suggestive, it is more common when 
Figure 1. Holter electrocardiography (ECG) monitoring results. Predominant cardiac rhythm from DDD pacemaker ca. 60 beats/min. After 
fi rst and fi fth heartbeat, pacemaker inhibition is present, reaching over 1.4 second and 1.8 second. There is no artefact associated with 
myopotentials in this ECG recording
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the lead is implanted using subclavian vein puncture, 
than through cephalic vein venesection. Presented recor-
dings confirm that bipolar pacemaker may be inhibited 
by myopotentials, which usually is associated with lead 
damage and should influence patient management. 
Our patient underwent transvenous lead extraction and 
during the same procedure new ventricular lead was 
implanted.
Figure 2. Electrocardiography and IEGM during pacemaker control. Letters N and n indicate ventricular lead noise. Noise marked with letter 
N (beyond VRP) was interpreted as ventricular activity (VS) from which the pacemaker started to count AEI and subsequently paced the 
atrium. Ventricular lead noise marked with letter n indicates noise which amplitude was too small to be detected by pacemaker as ventri-
cular activity. LRI_Res = remaining part of lower rate interval (LRI) after sensed ventricular event; VS_Ref = ventricular event sensed during 
ventricular refractory period. Other abbreviations are defi ned in the text
Streszczenie
Przedstawiono zapis 24-godzinnego monitorowania elektrokardiografi cznego metodą Holtera z obserwowanymi zaha-
mowaniami stymulacji kardiostymulatora typu DDD. Dyskutowane wyniki monitorowania holterowskiego są zagadkowe 
i mogą wynikać z zaburzeń wyczuwania kardiostymulatora. Ich etiologia może być jednak zróżnicowana. Zaprezentowa-
no szczegółowe wytłumaczenie mechanizmów oraz przegląd literatury.
Słowa kluczowe: hamowanie kardiostymulatora, tryb DDD
(Folia Cardiologica 2015; 10, 2: 133–135)
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